Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_assertion type Assertion NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_head.
- NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_assertion description "[We have demonstrated previously that the administration of CTLA-4 blockade has mediated objective cancer regression and autoimmunity in patients with metastatic melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_provenance.
- NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_assertion evidence source_evidence_literature NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_provenance.
- NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_assertion SIO_000772 16301685 NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_provenance.
- NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_assertion wasDerivedFrom befree-2016 NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_provenance.
- NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_assertion wasGeneratedBy ECO_0000203 NP523482.RA48sJ210q2enOC1wezFwziSIBKGaGj4AhpWdbGSNP1bs130_provenance.